| Name | N-[3-[1-[2-(8-chloro-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepin-11-yl)-2-oxoethyl]piperidin-4-yl]propyl]-N-ethyl-2,2-dimethylpentanamide |
|---|
| Description | BIBN-99 is a selective, BBB-penetrable and competitive muscarinic M2 receptor antagonist. BIBN-99 improves cognitive performancein rats with traumatic brain injury[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.172g/cm3 |
|---|---|
| Boiling Point | 709.8ºC at 760mmHg |
| Molecular Formula | C31H42ClN5O3 |
| Molecular Weight | 568.15000 |
| Flash Point | 383.1ºC |
| Exact Mass | 567.29800 |
| PSA | 89.34000 |
| LogP | 5.95490 |
| Vapour Pressure | 5.35E-20mmHg at 25°C |
| Index of Refraction | 1.561 |